ACTU logo

ACTU
Actuate Therapeutics Inc.

150
Mkt Cap
$71.13M
Volume
49,022.00
52W High
$11.99
52W Low
$1.58
PE Ratio
-2.79
ACTU Fundamentals
Price
$2.95
Prev Close
$3.00
Open
$2.98
50D MA
$2.71
Beta
1.09
Avg. Volume
219,063.80
EPS (Annual)
-$1.06
P/B
8.80
Rev/Employee
$0.00
$115.90
Loading...
Loading...
News
all
press releases
Short Interest in Actuate Therapeutics, Inc. (NASDAQ:ACTU) Grows By 40.1%
Actuate Therapeutics, Inc. (NASDAQ:ACTU - Get Free Report) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totaling 914,989 shares, an increase of 40.1% from the March 31st total of 653,203 shares. Currently, 12.6% of the company's...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
HC Wainwright Reiterates "Buy" Rating for Actuate Therapeutics (NASDAQ:ACTU)
HC Wainwright reaffirmed a "buy" rating and set a $15.00 target price on shares of Actuate Therapeutics in a research note on Wednesday...
MarketBeat·12d ago
News Placeholder
Why Did Actuate Therapeutics (ACTU) Stock Jump Over 14% After Hours?
Actuate Therapeutics shares surged 14.41% after-hours after Nature Medicine published Phase 2 data showing elraglusib plus chemotherapy improved overall survival in metastatic pancreatic cancer.read...
Benzinga·19d ago
News Placeholder
Actuate Therapeutics (NASDAQ:ACTU) Raised to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Actuate Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·1mo ago
News Placeholder
Voss Capital LP Boosts Stake in Actuate Therapeutics, Inc. $ACTU
Voss Capital LP raised its holdings in shares of Actuate Therapeutics, Inc. (NASDAQ:ACTU - Free Report) by 213.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·2mo ago
News Placeholder
Actuate Therapeutics (NASDAQ:ACTU) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen downgraded shares of Actuate Therapeutics from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·2mo ago
News Placeholder
Actuate Therapeutics (NASDAQ:ACTU) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded Actuate Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·3mo ago
News Placeholder
Mettler-Toledo Q4 Earnings Top Estimates, Sales Rise Y/Y
MTD beats Q4 estimates as adjusted EPS jumps 8% Y/Y and sales rise to $1.13B, led by solid growth across Laboratory, Industrial and Food Retail.
Zacks·3mo ago
News Placeholder
Actuate Therapeutics, Inc. (NASDAQ:ACTU) Sees Significant Growth in Short Interest
Actuate Therapeutics, Inc. (NASDAQ:ACTU - Get Free Report) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totaling 529,786...
MarketBeat·4mo ago
News Placeholder
Actuate Therapeutics (NASDAQ:ACTU) Downgraded by Wall Street Zen to "Sell"
Wall Street Zen downgraded Actuate Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·4mo ago
<
1
2
...
>

Latest ACTU News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.